Psychedelic Therapies Surge Amid Big Pharma Deal | Business and Finance News

Big moves in the market today as Eli Lilly’s $3.8B acquisition of AtaiBeckley sends psychedelics stocks soaring — with AtaiBeckley up 34% and COMPASS Pathways down 6.6% — fueling investor excitement over mental health breakthroughs and reshaping the future of biotech. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/04bdbda117a4b2d7